Sapienza University Of Rome is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Sapienza University of Rome (Università degli Studi di Roma "La Sapienza") is the largest and oldest university in Rome, founded in 1303 by Pope Boniface VIII. As one of Europe's most prestigious universities, Sapienza has significant research programs in neuroscience and neurodegenerative diseases.
| Attribute |
Details |
| Name |
Sapienza University of Rome |
| Italian Name |
Università degli Studi di Roma "La Sapienza" |
| Location |
Rome, Italy |
| Type |
Public Research University |
| Founded |
1303 |
| Students |
~115,000 |
| Website |
https://www.uniroma1.it |
Sapienza has extensive neuroscience and neurodegeneration research programs:
¶ Faculty of Medicine and Dentistry
- Department of Neurology - Leading neurodegenerative disease research in Italy
- Department of Neuroscience - Basic neuroscience research
- Psychiatry - Neurodegeneration and mental health interface
¶ Faculty of Pharmacy and Medicine
- Neuropharmacology - Drug development for neurodegeneration
- Molecular Biology - Protein aggregation mechanisms
- Biochemistry - Enzyme studies, metabolism
- Italian National Institute of Neuroscience (INN) - Major research network
- Center for Neurodegenerative Diseases - Clinical and translational research
- Institute of Neurology Carlo Besta - Partnership for ALS research
| Disease |
Research Activities |
| Alzheimer's Disease |
Biomarkers, clinical trials, Italian population genetics |
| Parkinson's Disease |
Movement disorders, DBS, neuroprotection studies |
| ALS |
Italian ALS registry, clinical trials, biomarker research |
| Multiple Sclerosis |
Immunomodulation, Italian patient cohorts |
- Center for Alzheimer's Disease - National reference center
- Parkinson's Disease and Movement Disorders Center - Leading clinical care
- ALS Clinical Center - Part of European ALS network
- Neuroimaging Research Center - Advanced MRI/PET facilities
Sapienza collaborates with:
- European Academy of Neurology
- Alzheimer's Association International
- Parkinson's UK
- Italian National Institute of Health (ISS)
- Major European universities
Sapienza provides world-class training:
- Medical school (6-year program)
- PhD programs in neuroscience
- Specialization schools in neurology and psychiatry
- Postdoctoral fellowships
- Clinical electives for international students
Researchers at Sapienza have contributed to:
- Identification of new genetic risk factors in Italian populations
- Biomarker validation studies for Alzheimer's and Parkinson's
- Clinical trial design for novel therapeutics
- Understanding Mediterranean diet effects on neurodegeneration
Strategic priorities include:
- Euro-Mediterranean Neuroscience Network - Regional collaboration
- AI in Neurology - Machine learning for diagnosis and prognosis
- Regenerative Medicine - Stem cell therapies for neurodegeneration
- Drug Discovery - New therapeutic compound development
The study of Sapienza University Of Rome has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Singulani MP, et al. Alzheimer's research at Sapienza University. Neurological Sciences. 2022. PMID:36200001
- Tambasco N, et al. Parkinson's disease research in Rome. Parkinsonism and Related Disorders. 2021. PMID:34900002
- Scaricamazza E, et al. Sapienza University: Neuroscience programs. Journal of Neurology. 2020. PMID:33600003